Mandate

Vinge advises HH Ferries

September 21, 2018 EU, Competition and Regulatory

Vinge has advised HH Ferries in an action before the EU General Court in Luxembourg in state aid proceedings which primarily relate to state guarantees.

The General Court approved HH Ferries’ action due to, among other things, the European Commission’s deficient review of the amount and time limits as well as the support measures’ proportionality and necessity and thus set aside the European Commission’s decision. 

Vinge’s team primarily consisted of Martin Johansson at the Brussels office as well as Rikard Azelius and Pär Remnelid at the Skåne office.

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026